CA Stock MarketDetailed Quotes

RX Biosyent Inc

Watchlist
  • 11.200
  • 0.0000.00%
15min DelayTrading Mar 17 16:00 ET
126.15MMarket Cap17.39P/E (TTM)

About Biosyent Inc Company

Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn, and Tibella.m.

Company Profile

SymbolRX
Company NameBiosyent Inc
Founded1947
MarketTSX
Fiscal Year Ends12-31
Address2476 Argentia Road Suite 402
CityMississauga
CountryCAN
Zip CodeL5N 6M1
Phone+1 905 206-0013

Company Executives

  • Name
  • Position
  • Salary
  • Rene C. Goehrum
  • Chairman of the Board, President and Chief Executive Officer
  • --
  • Robert J. March
  • Vice President and Chief Financial Officer
  • --
  • Joost van der Mark
  • Vice President, Corporate Development
  • --
  • Kevin Wilson
  • Vice President, Community Health Business
  • --
  • Dr. Navid Ashrafi, M.D.
  • Director, Medical and Regulatory Affairs
  • --
  • Stephen Wilton
  • Independent Director
  • --
  • Joseph Arcuri
  • Independent Director
  • --
  • Peter D. Lockhard
  • Lead Independent Director
  • --
  • Larry Andrews
  • Independent Director
  • --
  • Sara C. Elford
  • Independent Director
  • --
Trending Stocks
Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.